CTRI/2020/05/025440招募中未知
A randomised controlled trial comparing safety and efficacy of short course versus CRP guided antibiotic regimen for blood culture negative suspected neonatal sepsis
CMC hospital Vellore0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1 Symptoms criteria
- •b Hyperthermia
- •c Respiratory distress
- •d Poor feeding
- •f Irritability
- •g Hypothermia
- •h Hypotension
- •i Poor perfusion
- •k Feed intolerance
- •2 Laboratory criteria
- •a Have a total WBC count more than 5000 per cubic millimeter
- •b Have an Absolute Neutrophil Count more than 1500 per cubic millimeter
- •3 Baby becomes asymptomatic and are clinically well within 24 hours of suspicion of sepsis with following criteria
- •a Normal activity
- •b Stable temperature
- •c Stable hemodynamic status with no need for inotropes
- •d No respiratory support needed like supplementary oxygen CPAP ventilation
排除标准
- •1 They have received antibiotics in the past 15 days
- •2 They have had surgery in the past 7 days
- •3 Total WBC count less than 5000 per cubic millimeter
- •4 Have an Absolute Neutrophil Count less than 1500 per cubic millimeter
- •5 Abnormal activity beyond 24 hours of suspicion of sepsis
- •6 Unstable temperature beyond 24 hours of suspicion of sepsis
- •7 Unstable hemodynamic status requiring inotropes
- •8 Respiratory support needed like supplementary oxygen CPAP ventilation
研究者
相似试验
尚未招募
不适用
Comparison of intravenous iron preparations in iron deficiency anemia in pregnancyCTRI/2018/12/016771Department of OBGY
尚未招募
4 期
Comparison of inhalational new drug vilanterol fluticasone furoate combination with salmeterol fluticasone furoate combination for reversible respiratory obstructive disease.CTRI/2024/04/066334Central Research And Publication Unit
尚未招募
Unknown
To compare safety and efficacy of propranolol with flunarizine in adult patients suffering from migraine as prophylactic drugs.CTRI/2023/06/053593Dr. Rajendra Prasad Government Medical College
进行中（未招募）
不适用
A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel plus or minus Sorafenib (BAY 43-9006) in chemonaive patients with Stage IIIB (with effusion) - IV Non-Small Cell Lung Cancer (NSCLC) - ESCAPEEUCTR2005-005245-19-DEBayer Pharmaceuticals Corporation900
进行中（未招募）
不适用
A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel plus or minus Sorafenib (BAY 43-9006) in chemonaive patients with Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)on Small Cell Lung CancerMedDRA version: 8.1Level: PTClassification code 10061873EUCTR2005-005245-19-HUBayer Pharmaceuticals Corporation900